CardioComm Solutions (EKG.V) Osake Kurssi

CardioComm Solutions Inc is primarily active in the healthcare technology industry.

The main competitors of CardioComm Solutions Inc in the market include companies such as Medtronic, Philips Healthcare, and AliveCor.

CardioComm Solutions Inc., a leading provider of digital health software solutions, has an impressive history and background. Established in 1994, the company has been at the forefront of advancing remote monitoring technologies for cardiovascular health. With their flagship product, the GlobalCardio™ ECG device, CardioComm Solutions revolutionized telemedicine by enabling accurate, real-time transmission of patient ECG data to healthcare professionals. Over the years, the company has continually evolved, introducing innovative products and solutions designed to enhance patient care, including the FDA-cleared CardioComm HeartCheck™ ECG pen. Today, CardioComm Solutions Inc. remains dedicated to leveraging technology to improve cardiovascular diagnostics and monitoring, making them a trusted name in the digital health industry.

CardioComm Solutions Inc has achieved several significant milestones throughout its history. The company has successfully developed and commercialized innovative medical software solutions focused on the diagnosis and management of cardiac patients. Some key achievements include the clearance and approval of their ECG management software by regulatory authorities like the FDA and Health Canada. CardioComm Solutions Inc has also established strategic partnerships with renowned healthcare organizations and industry leaders, expanding their global reach and market presence. These milestones highlight the company's commitment to advancing cardiovascular healthcare through cutting-edge technology and their strong commitment to delivering high-quality solutions to healthcare practitioners and patients worldwide.

CardioComm Solutions Inc is primarily present in several countries and regions. The company's operations extend to North America, including the United States and Canada. With a focus on providing innovative cardiac monitoring solutions, CardioComm Solutions Inc also serves customers in Europe, including the United Kingdom, Germany, France, and Italy. Additionally, the company's presence reaches Asia, catering to markets in Japan and China. With its global footprint, CardioComm Solutions Inc aims to deliver its cutting-edge technologies and services to healthcare professionals and patients worldwide.

CardioComm Solutions Inc represents a strong commitment to innovation, technological advancements, and quality healthcare solutions. With a focus on developing and marketing high-quality electrocardiogram (ECG) software and devices, the company aims to improve patient care and outcomes. CardioComm Solutions Inc prioritizes excellence in product development, ensuring their solutions meet stringent medical standards. The company's corporate philosophy centers around providing healthcare providers with reliable and user-friendly tools to enhance the diagnosis and management of cardiac conditions. By embracing cutting-edge technologies and a patient-centric approach, CardioComm Solutions Inc strives to be a leader in the field of cardiac care.

Nykyisellä valuuttakurssilla CardioComm Solutions-osake noteerataan hintaan 0,01 EUR (0,01 CAD).

CardioComm Solutions Inc. is a company that specializes in innovative solutions in the field of telemedicine and telecardiological monitoring. The company offers a wide range of products and services to improve cardiac diagnosis, monitoring, and care. The business model of CardioComm Solutions Inc. is based on several divisions, including the development and marketing of software, hardware, and cloud-based solutions. The company's main products include Smart ECG and GEMS Home System, which can be used to monitor heart rate, ECG, and other cardiac parameters. These products are capable of collecting and analyzing real-time data, enabling remote patient monitoring, particularly in rural and remote areas or for patients with special needs. Another important component of CardioComm Solutions Inc.'s business model is the sale of license and service agreements. This includes rights to patented technologies, as well as physician-patient communication and other security requirements. In collaboration with medical facilities, health systems, private clinics, and companies, the company offers a wide range of services including telemedicine needs analysis and consultation, installation, and support. To succeed in the market, CardioComm Solutions Inc. relies on close collaboration with medical facilities, research institutions, and universities. It constantly works to improve its products and services and drive application-oriented innovations. The company takes pride in its ability to analyze complex data in real-time and provide medically relevant information to enable doctors and medical personnel to achieve the best possible diagnosis and treatment outcomes. As a company, CardioComm Solutions Inc. adopts a future-oriented strategy characterized by adherence to high standards, close collaboration and partnership, and continuous investment in innovative technologies and the ongoing improvement of products and services. The company is headquartered in Toronto, Canada, and operates worldwide. Customers can rely on reliable and professional support. A tailored solution is always developed to ensure the best possible outcome. In summary, the business model of CardioComm Solutions Inc. is characterized by the development and marketing of telemedicine monitoring solutions, such as Smart ECG and GEMS Home System, which are used to monitor the patient's cardiac parameters. The company also offers license and service contracts, including telemedicine needs analysis and consultation, installation, and support. The company always prioritizes innovation and collaboration and is ready to quickly and flexibly respond to new requirements to meet customer needs.

Liikevaihtoa ei voida laskea CardioComm Solutions:lle tällä hetkellä.

Voittoa ei voida laskea CardioComm Solutions:lle tällä hetkellä.

P/E-suhdetta ei voida laskea CardioComm Solutions:lle tällä hetkellä.

P/S-suhdetta ei voida laskea CardioComm Solutions:lle tällä hetkellä.

CardioComm Solutions:n Eulpool-laatuscore on 1/10.

CardioComm Solutions:n ISIN on CA14159N2086. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

CardioComm Solutions:n WKN on A0M8Q9. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

CardioComm Solutions:n ticker on EKG.V. Tämä pörssinoteeraus käytetään CardioComm Solutions-osakkeiden kauppaan pörssissä.